About VisualDx

Version: 6.13.1083    (Build 6410)

© 2000-2010 Logical Images, Inc. All rights reserved. Patent pending.

VisualDx is a registered trademark of Logical Images, Inc.


Medical Disclaimer:

The information contained in this software package is intended to be an adjunct to traditional medical information sources. This software is not intended to be a substitute for professional medical judgment.

The practice of medicine is a complex process that involves the synthesis of information from a multiplicity of sources. The information contained in this software delivers similar information to that of a textbook and is but one of the sources that may be used in establishing a diagnosis for a patient. Logical Images, Inc., accepts no responsibility for the correctness of any diagnosis based in whole or in part upon the use of this software.

This software is provided to make access to referential medical information faster and to make the search for that medical information available through multiple search paths.



Image Contributors:
Carl Allen DDS, MSD
Brandon Ayres MD
Robert Baran MD
Donald Belsito MD
William Bonnez MD
Sarah Brenner MD
Robert Brodell MD
Sean P. Bush, MD, FACEP
Jeffrey Callen MD
Scott Camazine, MD
Michael Cardwell
Robert Chalmers MD, MRCP, FRCP
Flavio Ciferri MD
Noah Craft MD, PhD
Charles Crutchfield III MD
Bart J. Currie MBBS, FRACP, DTM&H
C. Ralph Daniel III MD
Ncoza Dlova MD
James Earls MD
David Elpern MD
Nancy Esterly MD
Stephen Estes MD
E. Dale Everett MD
Janet Fairley MD
David Feingold MD
Benjamin Fisher MD
David Foster MD, MPH
Michael Franzblau MD
Vincent Fulginiti MD
Lowell Goldsmith MD, MPH
Bernardo Gontijo MD, PhD
Kenneth Greer MD
Alan Gruber MD
Vidal Haddad MSC, PhD, MD
John Harvey
Peter W. Heald, MD
Li-Yang Hsu MD
Shahbaz A. Janjua MD
Robert Kalb MD
Henry Kempe MD
Loren Ketai MD
Sidney Klaus MD
Carl Krucke
Sue Lewis-Jones FRCP, FRCPCH
Edith Lederman MD
Taisheng Li MD
Jason Maguire MD
Mark Malek, MD, MPH
Ricardo Mandojana MD
Lynne Margesson MD
Karen McKoy MD
Thomas McMeekin MD
Mary Gail Mercurio MD
Larry E. Millikan MD
Dean Morrell, MD
Samuel Moschella MD
Taimor Nawaz MD
Vic Newcomer MD
Steven Oberlender MD, PhD
Maria Teresa Ochoa MD
Art Papier MD
Lawrence Parish MD
Robert Penne MD
Christopher J. Rapuano MD
Sireesha Reddy, MD
Angela Restrepo MD, PhD
Bertrand Richert MD, PhD
Daniel Sexton MD
Paul K. Shitabata, MD
Tor Shwayder, MD, FAAP, FAAD
Elaine Siegfried MD
Mary J. Spencer, MD, FAAP
Sarah Stein MD
William Van Stoecker MD
Frances J. Storrs MD
Jenny Valverde MD
Susan Voci MD
Lisa Wallin ANP, FCCWS
George Watt MD
Sally-Ann Whelan, MS, NP, CWOCN
Jan Willems MD, PhD
Karen Wiss MD
Sook-Bin Woo MS, DMD, MMSc

Am. Journal of Trop. Med & Hygiene
Armed Forces Pest Management Board
Blackwell Publishing
Bugwood Network
Centers For Disease Control and Prevention
International Atomic Energy Agency
Massachusetts Medical Society
Radiological Society of North America
Wikipedia
World Health Organization
Contact Us
Support/Customer Service:
Please call Logical Images, Inc., at 800-357-7611 (US only) or e-mail us at support@logicalimages.com.
Sales:
Please call Logical Images, Inc., at 800-357-7611 (US only) or send e-mail to sales@logicalimages.com.
Copyright Notice

Images, Text and Knowledge contained within VisualDx are copyright protected and should not be copied, pasted, used in presentations, printed or used in any other manner than viewing within VisualDx.

Logical Images respects the intellectual property of others, and we ask our users to do the same. The images, text, design and database of VisualDx are protected by copyright and the intellectual property laws of the United States and/or other countries. It is Logical Images's policy, in appropriate circumstances and at its discretion, to disable and/or terminate the accounts of users who infringe our copyright and the copyright of our image contributors.

Clinical Scenario
Adult Rash
Last Updated: 12/31/2009
702.0 – Actinic keratosis
Actinic, or solar, keratosis is a neoplastic condition in which precancerous epithelial lesions are found on sun-exposed areas of the body. This is a very common condition in fair-skinned individuals (eg, northern European descent) and virtually unseen in people of darker skin types. They are commonly seen on sun-exposed skin of the face, neck, upper chest, forearms, and dorsal hands. These flat, scaly papules are of varying sizes and usually begin as "rough" localized skin lesions that the patient feels but are difficult to see. Actinic keratoses have the potential to evolve into squamous cell carcinoma. They are usually asymptomatic but may be pruritic or painful. The frequency of actinic keratoses increases with increasing age and cumulative lifetime sun exposure. They are also more common in immunosuppressed individuals. They may resolve with protection from UV light. Patients with actinic keratoses are also at higher risk for developing non-melanoma skin cancer. 
Subtle, barely elevated to thicker, hypertrophic, rough papules with ill-defined borders. There may be adherent scale with color variation from whites to yellows and, more rarely, a reddish-brown or gray-colored scale. The papules usually have an underlying red base. Size varies. When large in number, actinic keratoses may coalesce to form plaques. Lower lip involvement with actinic keratoses is considered actinic cheilitis.
Actinic keratoses are often more easily palpated (with light touch) than seen.
This is a clinical diagnosis. If necessary, confirm with a skin biopsy. Biopsies should be performed on recurrent, hyperkeratotic, large (greater than 6 mm), or indurated lesions to rule out invasive carcinoma. 
Aggressive sun avoidance / sun-protective measures should be instituted. Patients should wear protective clothing, broad-brimmed hats, and a broad spectrum (UVA and UVB blocking) sunscreen with SPF 30 or higher when exposed to the sun.

If patient does not respond to therapy, perform a biopsy to rule out squamous cell carcinoma.
Treat individual lesions with liquid nitrogen cryotherapy or superficial curettage and cautery.

5-Fluorouracil 5% cream (Efudex®, Fluoroplex®) can be applied twice daily to areas of more extensive involvement for about 2 weeks. It will cause a vigorous reaction (redness, hemorrhagic crusting). Have the patient apply an emollient such as petroleum jelly to aid in crust dissolution.
 
Other treatments that may be tried include:
  • Topical imiquimod 5% cream applied to affected areas 2–3 times per week for 12 weeks
  • Photodynamic therapy with methyl aminolevulinate
  • 0.3% Topical adapalene gel applied to affected areas 1–2 times daily
  • Topical 3.0% diclofenac in 2.5% hyaluronan gel applied to affected areas twice daily
A low-fat diet (less than 21% of calories from fat) has been shown to reduce the incidence of actinic keratoses. Actinic keratoses will decrease and sometimes resolve with sunscreen use.
Duncan KO, Geisse JK, Leffell DJ. Epithelial precancerous lesions. In: Fitzpatrick TB, Wolff K, eds. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York, NY: McGraw-Hill; 2008:1007-1015.

Ben M'barek L, Mebazaa A, Euvrard S, Frances C, Thervet E, Morel P, Menasché S, Legendre C, Lebbe C. 5% topical imiquimod tolerance in transplant recipients. Dermatology. 2007;215(2):130-3. PubMed Id: 17684375

Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, Roelandts R, Wennberg AM, Morton CA, International Society for Photodynamic Therapy in Dermatology. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007 Jan;56(1):125-43. PubMed Id: 17190630

Falagas ME, Angelousi AG, Peppas G. Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2006 Sep;55(3):537-8. PubMed Id: 16908371

James WD, Berger TG, Elston DM. Epidermal Nevi, neoplasms, and cysts. In: James WD, Berger TG, Elston DM, Odom RB, eds. Andrews' Diseases of the Skin: Clinical Dermatology. 10th ed. Philadelphia, PA: Saunders Elsevier; 2006:641-643.

Lee PK, Harwell WB, Loven KH, Phillips TJ, Whiting DA, Andres KL, Lee JH. Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream. Dermatol Surg. 2005 Jun;31(6):659-64. PubMed Id: 15996416

Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, Bichel J, Lee JH, Fox TL, Alomar A. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol. 2004 Oct;51(4):547-55. PubMed Id: 15389189

Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):11-7. PubMed Id: 10607351

Black HS, Herd JA, Goldberg LH, Wolf JE, Thornby JI, Rosen T, Bruce S, Tschen JA, Foreyt JP, Scott LW, et al. Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med. 1994 May 5;330(18):1272-5. PubMed Id: 8145782

Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993 Oct 14;329(16):1147-51. PubMed Id: 8377777
Appearance
No Acute Distress

Body Location
Anterior Lower Leg
Anti-Helical Rim of Ear
Arm
Cheek
Dorsum of Hand
Ear
Eyebrow
Face
Fingers
Forearm
Forehead
Frontal Scalp
Hand or Fingers
Helical Rim of Ear
Lips
Lower Leg
Nose
Occipital Scalp
Posterior Aspect of Ear
Superior Chest
Superior Eyelid
Superior Lip
Temple
Upper Arm
Upper Back
Vertex Scalp

Distribution
Photodistributed (Sun-Exposed)
Unilateral

Exposures
Sun Exposure - History of Severe Sunburns

Lesion
Auspitz Sign
Scaly Papule

Occupations
Military

Signs and Symptoms
No Fever (Afebrile, Apyrexial)

Temporal
Developed Chronically Lasting Months to Years
Developed Steadily Over Weeks to Months

Medical History
Bone Marrow Transplant
Immunosuppression/Immunocompromised
S-P Organ Transplant NOS
S-P Renal Transplant

Authors
Noah Craft MD, PhD, Lindy P. Fox MD, Lowell A. Goldsmith MD, MPH, Michael D. Tharp MD